Inventor
PETERSEN KIRSTIN
DE28 patents
⚠️ This page may combine multiple inventors who share the name “PETERSEN KIRSTIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
Bayer Pharma AG
9 patentsUS9409889B2Aug 9, 2016
Amino-substituted imidazopyridazines
Bayer Pharma AG3 citations72
US10717749B2Jul 21, 2020
Macrocyclic sulfondiimine compounds
Bayer Pharma AG2 citations70
US9382255B2Jul 5, 2016
Substituted pyrrolopyrimidinylamino-benzothiazolones as MKNK kinase inhibitors
Bayer Pharma AG3 citations70
US10214542B2Feb 26, 2019
Modified macrocyclic compounds
Bayer Pharma AG2 citations61
US10487092B2Nov 26, 2019
Pyrazolopyridinamines as MKNK1 and MKNK2 inhibitors
Bayer Pharma AG1 citations60
US11427578B1Aug 30, 2022
Substituted pyrrolopyridine-derivatives
Bayer Pharma AG1 citations55
US10214545B2Feb 26, 2019
Amido-substituted imidazopyridazines useful in the treatment of hyper-proliferative and/or angiogenesis disorders
Bayer Pharma AG0 citations41
US9783543B2Oct 10, 2017
Aminoimidazopyridazines
Bayer Pharma AG0 citations41
US9745304B2Aug 29, 2017
Amidoimidazopyridazines as MKNK-1 kinase inhibitors
Bayer Pharma AG0 citations41
PETERSEN KIRSTIN
4 patentsUS9366395B2Jun 14, 2016
Optical element, optoelectronic component and method for the production thereof
PETERSEN KIRSTIN8 citations81
US8962361B2Feb 24, 2015
Method for producing a semiconductor chip emitting radiation, semiconductor chip emitting radiation, and component emitting radiation
PETERSEN KIRSTIN4 citations71
US8585246B2Nov 19, 2013
Optoelectronic module and projection apparatus comprising the optoelectronic module
PETERSEN KIRSTIN1 citations50
US9142731B2Sep 22, 2015
Method for producing a luminescence conversion substance layer, a composition therefor and a component comprising such a luminescence conversion substance layer
PETERSEN KIRSTIN0 citations40
BAYER AG
4 patentsUS11339157B1May 24, 2022
4H-pyrrolo[3,2-c]pyridin-4-one derivatives
BAYER AG2 citations69
US11998539B2Jun 4, 2024
Substituted aminoquinolones as DGKalpha inhibitors for immune activation
BAYER AG1 citations59
US12478621B2Nov 25, 2025
Substituted aminoquinolones as dgkalpha inhibitors for immune activation
BAYER AG0 citations58
US11964953B2Apr 23, 2024
Substituted aminothiazoles as DGKzeta inhibitors for immune activation
BAYER AG0 citations56